REGENXBIO SINKS AS FDA PUTS RGX-121 GENE THERAPY ON CLINICAL HOLD - SEEKINGALPHA
FDA clinical hold on RGX-121 triggers regulatory uncertainty, driving sharp downside for REGENXBIO.
What changed
FDA clinical hold on RGX-121 triggers regulatory uncertainty, driving sharp downside for REGENXBIO.
Why it matters
FDA clinical hold on RGX-121 triggers regulatory uncertainty, driving sharp downside for REGENXBIO. — impact context not separately stored; see What changed.
← Dashboard
Aug 24, 2026 11:57 AM ET